Company Directory > CDMO > Inpharma

Inpharma

Praia, Cabo Verde
VISIT WEBSITE
Inpharma is the leading pharmaceutical manufacturer in Cabo Verde, established to reduce the country's dependence on imported medicines. The company specializes in the production, commercialization, and export of generic medicines, hygiene products, and cosmetics. It operates a modern manufacturing facility in Praia that produces solid and liquid oral forms, as well as topical treatments. In recent years, Inpharma has transitioned from a domestic-focused supplier to a regional exporter, targeting the PALOP (Portuguese-speaking African countries) and West African markets. The company is currently undergoing significant expansion, supported by international financing, to upgrade its facilities to meet World Health Organization (WHO) Good Manufacturing Practice (GMP) standards and increase its export capacity.
CLASSIFICATION
Company Type:CDMO
Industry:Pharmaceuticals
Sub-Industry:Generic Manufacturing
SIZE & FINANCIALS
Employees:101-250
Revenue:$10M-$50M
Founded:1991
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Total Raised:$10.8M
Investors:African Development Bank (ADB), Emprofac, Labesfal Farma Cabo Verde
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Topical creams, Oral liquids, Solid dosage forms
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Emprofac (Exclusive distribution partner in Cabo Verde), Marchesini Group (Packaging technology partner), WAHO (West African Health Organisation) for regional harmonization
COMPETITION
Position:Leader
Competitors:Bosnalijek, Regional generic manufacturers in Senegal and Nigeria
LEADERSHIP
Key Executives:
Joaquim Coimbra - Chairman of the Board (PCA)
Elisete Lima - Director General
Edith Santos - Technical Director of Regulatory Affairs
Board Members:Luís Vasconcelos Lopes, Ana Filomena Soares da Cruz, Sandra Patrícia Almiro Coimbra
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Inpharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.